Enalapril in paediatric patients with Alport syndrome: 2 years' experience

European Journal of Pediatrics

Volumn 159, Issue 6, 2000, Pages 430-433

  Proesmans, Willem ^a   Knockaert, Hilde ^a   Trouet, Dominique ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Alport syndrome; Angiotensin converting enzyme inhibitors; Children; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ALPORT SYNDROME; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HYPERTENSION; MALE; NEPHRITIS; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; ENALAPRIL; FEMALE; HUMANS; MALE; NEPHRITIS, HEREDITARY; TIME FACTORS;

EID: 0034111184     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051301     Document Type: Article

References (10)

1. Anderson S, Rennke H, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000
2. Feingold G, Bois E, Chrompel A, Broyer M, Gubler MC, Grünfeld G (1985) Genetic heterogeneity of Alport syndrome. Kidney Int 27: 672-677
3. Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter B, Valli VE, Jacobs RM (1997) Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 117: 209-225
4. Mashio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zuchelli P and the angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group (1996) Effect of the angiotension-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945
5. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroeder CH, Smeets HJM, Reeders T (1994) Identification of mutations in the a3(IV) and a4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-82
6. Parving HH, Hommel E, Smidt EM (1988) Protection of the kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086-1091
7. Proesmans W, Van Wambeke I, Van Dyck M (1996) Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol 10: 587-589
8. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M (1993) Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118: 577-581
9. Trachtman H, Gauthier B (1988) Effect of angiotensin converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112: 295-298
10. Tryggvason K, Zhou J, Hostikka SL, Shows TB (1993) Molecular genetics of Alport syndrome. Kidney Int 43: 38-44